Investigating Disease Mechanisms and Drug Response Differences in Transcriptomics Sequencing Data

Date
2022-01
Language
American English
Embargo Lift Date
Department
Committee Chair
Degree
Ph.D.
Degree Year
2022
Department
Grantor
Indiana University
Journal Title
Journal ISSN
Volume Title
Found At
Abstract

In eukaryotes, genetic information is encoded by DNA, transcribed to precursor messenger RNA (pre-mRNA), processed into mature messenger RNA (mRNA), and translated into functional proteins. Splicing of pre-mRNA is an important epigenetic process that alters the function of proteins through modifying the exon structure of mature mRNA transcripts and is known to greatly contribute to diversity of the human proteome. The vast majority of human genes are expressed through multiple transcript isoforms. Expression of genes through splicing of pre-mRNA plays crucial roles in cellular development, identity, and processes. Both the identity of genes selected for transcription and the specific transcript isoforms that are expressed are essential for normal cellular function. Deviations in gene expression or isoform proportion can be an indication or the cause of disease. RNA sequencing (RNAseq) is a high-throughput next-generation sequencing technology that allows for the interrogation of gene expression on a massive scale. RNAseq generates short sequences that reflect pieces of mRNAs present in a sample. RNAseq can therefore be used to explore differences in gene expression, reveal transcript isoform identities and compare changes in isoform proportions. In this dissertation, I design and apply advanced analysis techniques to RNAseq, phenotypic and drug response data to investigate disease mechanisms and drug sensitivity. Research Goals: The work described in this dissertation accomplishes 4 aims. Aim 1) Evaluate the gene expression signature of concussion in collegiate athletes and identify potential biomarkers for response and recovery. Aim 2) Implement a machine-learning algorithm to determine if splicing can predict drug response in cancer cell lines. Aim 3) Design a fast, scalable method to identify differentially spliced events related to cancer drug response. Aim 4) Construct a drug-splicing network and use a systems biology approach to search for similarities in underlying splicing events.

Description
Indiana University-Purdue University Indianapolis (IUPUI)
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Rights
Source
Alternative Title
Type
Dissertation
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}